Raphael Catane

9.4k citations
136 papers · 7.3k · 2 hit papers · h-index 38

Impact in

  • Biomaterials top 0.5%
    • Nanoparticle-Based Drug Delivery
  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • CAR-T cell therapy research

Papers in

Raphael Catane

133 papers receiving 7.0k citations

Raphael Catane's Hit Papers

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer 2004 · 1.3k citations
1.3k0+10+21Years since publication4008001.2k

Peers

Raphael Catane
Comparison fields: 5 of 143
  • Biomaterials 1.4k
  • Oncology 1.9k
  • Cancer Research 598
  • Genetics 855
  • Pulmonary and Respiratory Medicine 795
Replace O. Michael Colvin with:
O. Michael Colvin United States
Noriaki Ohuchi Japan
Nancy Hunter United States
Kurt R. Zinn United States
Frans H.M. Corstens Netherlands
Christoph Rochlitz Switzerland
William C. Zamboni United States
Beatrice Uziely Israel
Marc Dellian Germany
Karen K. Fu United States
Raphael Catane relative to O. Michael Colvin United States O. Michael Colvin's profile →
Citations per field
00.5×3.6×
O. Michael Colvin · 1×
Citations per year

Countries citing papers authored by Raphael Catane

Since Specialization
Citations

This map shows the geographic impact of Raphael Catane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Catane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Catane more than expected).

Fields of papers citing papers by Raphael Catane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Catane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Catane. The network helps show where Raphael Catane may publish in the future.

Co-authors

The 25 scholars most cited alongside Raphael Catane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphael Catane Line = papers co-authored together Raphael Catane links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Hit paper breakdown →
20041326
2
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Hit paper breakdown →
19941165
3 2010357
4 2005328
5
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
1997246
6 2014237
7 2008235
8 2006196
9 2006153
10 2001152
11 2003145
12 2006134
13 1994129
14 1989105
15 200099
16 200997
17
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
198088
18 198186
19 200378
20 199678

About Raphael Catane

Raphael Catane is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Genetics, having authored 136 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), BRCA gene mutations in cancer (12 papers), Prostate Cancer Treatment and Research (9 papers), Management of metastatic bone disease (7 papers), Chemotherapy-related skin toxicity (6 papers), Lung Cancer Research Studies (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Biomaterials (1.4k citations), Oncology (1.9k citations), Cancer Research (598 citations), Genetics (855 citations) and Pulmonary and Respiratory Medicine (795 citations). Raphael Catane has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Bella Kaufman, Beatrice Uziely, Alberto Gabizón, Nathan I. Cherny, Francisco J. Plaza Martín, Y. Barenholz, Bela Kaufman, Tamar Safra, Rivka Cohen and Anthony H. C. Huang. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Journal of Surgical Oncology, Annals of Oncology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact